Long-Term Beneficial Effects of Angiotensin-Converting Enzyme Inhibition in Patients With Nephrotic Proteinuria

American Journal of Kidney Diseases

Volumn 20, Issue 3, 1992, Pages 240-248

  Praga, Manuel ^a   Hernández, Eduardo ^a   Montoyo, Cecilia ^a   Andrés, Amado ^a   Ruilope, Luis M ^a   Rodicio, Jose L ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Angiotensin converting enzyme inhibition; progression of renal insufficiency; proteinuria; serum lipids

Indexed keywords

CAPTOPRIL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLASMA PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; ENZYME INHIBITION; FEMALE; FOLLOW UP; HUMAN; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; LIPID BLOOD LEVEL; MALE; NEPHROTIC SYNDROME; PROTEINURIA;

EID: 0026737608     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(12)80696-2     Document Type: Article

References (36)

1. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat
2. Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions
3. Both converting enzyme inhibitors and vasodilators reduce glomerular capillary pressure and injury in uninephrectomized spontaneously hypertensive rats
4. Effect of captopril and hydrochlorothiazide on glomerular haemodynamics and histological damage in Goldblatt hypertension with partial renal ablation
5. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension
6. Mechanisms underlying transition from acute glomerular injury to glomerulosclerosis in a rat model of nephrotic syndrome
7. Modulation of albuminuria by dietary protein and converting enzyme inhibition
8. Angiotensin converting enzyme inhibitors: The end of end-stage renal disease?
9. Progression of chronic renal failure
10. Effect of captopril on heavy proteinuria in azotemic diabetes
11. Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy
12. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy
13. Reduction of proteinuria by angiotensin converting enzyme inhibition
14. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril
15. Effects of ACE inhibition in normotensive patients with chronic glomerular disease and normal renal function
16. Nephrotic proteinuria without hypoalbuminemia: Clinical characteristics and response to angiotensin-converting enzyme inhibition
17. Antiproteinuric effect of captopril in primary glomerular disease
18. Renal effects of enalapril in hypertensive patients with glomerulonephritis
19. Effects of angiotensin converting enzyme inhibitors on the progression of renal failure and proteinuria in humans
20. Angiotensin converting enzyme inhibition improves glomerular sizeselectivity in IgA nephropathy
21. Chronic effects of dietary protein on renal structure and function in the rat with intact and reduced renal mass
22. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass
23. Importance of angiogenic action of angiotensin II in the glomerular growth of maturing kidneys
24. Effects of antihypertensive drugs on glomerular morphology
25. Effect of ACEinhibitors on anionic sites of glomerular basement membrane of puromycin nephrotic rats
26. ACEI inhibition improves glomerular permselectivity to proteins not to dextrans
27. Kinetics of immune deposits in membranous nephropathy
28. The nature of the glomerular injury in minimal change and focal sclerosing glomerulopathies
29. Converting enzyme inhibition in chronic renal failure
30. Interstitial nephritis induced by proteinoverload proteinuria
31. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?
32. Short- and long-term effects of antihypertensive therapy in the diabetic rat
33. The hyperlipidemia of the nephrotic syndrome: Relation to plasma albumin concentration, oncotic pressure and viscosity
34. Hypolipidemic effects of long-term antihypertensive treatment with captopril
35. Lipids and progressive glomerulosclerosis: A model analogous to atherosclerosis
36. Pharmacologic treatment of hyperlipidemia reduces glomerular injury in the rat 5/6 nephrectomy model of chronic renal failure